Synta Pharmaceuticals Email Format
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Synta Pharmaceuticals is a mid-sized biopharmaceutical company operating in the pharmaceutical manufacturing industry, focused on researching, developing, and commercializing oncology medicines. Its lead candidate, ganetespib, targets heat shock protein 90 and has been evaluated in several large randomized trials, including a Phase 3 study in non-small cell lung cancer. Ganetespib has been studied in approximately 1,350 patients to date. The company is pursuing a proprietary Drug Conjugate Program that uses Hsp90 inhibition to selectively deliver anti-cancer payloads, with the first clinical candidate, STA-12-8666, currently undergoing testing to support an IND filing. Synta is based in Conshohocken, Pennsylvania.